Ann Surg:切口iNPWT可降低术后伤口并发症的发病风险

2020-08-20 MedSci原创 MedSci原创

2016年WHO关于使用iNPWT预防SSI的建议是基于低水平的证据,此后许多试验相继发表。临床前证据表明,iNPWT还可以预防伤口开裂、皮肤坏死、血清肿和血肿。本研究旨在评估iNPWT预防术后伤口并

2016年WHO关于使用iNPWT预防SSI的建议是基于低水平的证据,此后许多试验相继发表。临床前证据表明,iNPWT还可以预防伤口开裂、皮肤坏死、血清肿和血肿。本研究旨在评估iNPWT预防术后伤口并发症(如SSI)的疗效。

在PubMed、EMBASE、CINAHL和CENTRAL中搜索比较iNPWT和对照敷料的随机和非随机研究。使用Cochrane偏倚风险工具、Newcastle-Ottawa量表和GRADE评估证据。使用随机效应模型进行了荟萃分析。

 

结果,高水平证据表明,iNPWT减少了SSI[28项RCTs,n = 4398,相对风险(RR)0.61,95%置信区间[CI]:0.49-0.76,P <0.0001,I = 27%],需要治疗的数量为19次。低水平证据表明,iNPWT可减少伤口开裂(16项RCTs,n = 3058,RR 0.78,95% CI:0.64-0.94)。很低水平的证据表明,iNPWT还减少了皮肤坏死(RR 0.49,95% CI:0.33-0.74)、血清瘤(RR 0.43,95% CI:0.32-0.59)和住院时间(汇总平均差异-2.01,95% CI:-2.99至1.14)。

总之,高水平的证据表明,切口iNPWT可降低SSI风险,且异质性有限。低至极低水平的证据表明,iNPWT还能降低伤口开裂、皮肤坏死和血清瘤的风险。

 

原始出处:

 

Pieter R ZwanenburgBerend T Tol, et al., Meta-analysis, Meta-regression, and GRADE Assessment of Randomized and Nonrandomized Studies of Incisional Negative Pressure Wound Therapy Versus Control Dressings for the Prevention of Postoperative Wound Complications. Ann Surg. 2020 Jul;272(1):81-91. doi: 10.1097/SLA.0000000000003644.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2036281, encodeId=deca203628110, content=<a href='/topic/show?id=f818130200e' target=_blank style='color:#2F92EE;'>#NPWT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13020, encryptionId=f818130200e, topicName=NPWT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af68384, createdName=hanhaisha2008, createdTime=Sat Sep 19 03:07:07 CST 2020, time=2020-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926968, encodeId=372592696812, content=👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210130/f777d0b91a25425ba588babbf050d6d1/328b4c90fd7741d090ece3b8f155fc70.jpg, createdBy=25525455713, createdName=牛, createdTime=Wed Feb 24 22:18:18 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1758277, encodeId=96171e5827764, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Fri Feb 26 11:07:07 CST 2021, time=2021-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811748, encodeId=99d4811e485c, content=值得学习及推荐, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210203/aa2a555e80164f58a3a144d7cc0799d9/dc80c6d00a7d4ebab61b224c64402143.jpg, createdBy=85733606129, createdName=185333828dm, createdTime=Fri Aug 21 14:49:23 CST 2020, time=2020-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811674, encodeId=ff4e8116e484, content=日常签到,赚点积分<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a> , beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201110/2d55d24dc5fd419d994b7b920c79731b/d3c8bdca983c4af1b90220a8192e353a.jpg, createdBy=e14e5296465, createdName=飞翔的乌龟, createdTime=Fri Aug 21 09:06:27 CST 2020, time=2020-08-21, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2036281, encodeId=deca203628110, content=<a href='/topic/show?id=f818130200e' target=_blank style='color:#2F92EE;'>#NPWT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13020, encryptionId=f818130200e, topicName=NPWT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af68384, createdName=hanhaisha2008, createdTime=Sat Sep 19 03:07:07 CST 2020, time=2020-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926968, encodeId=372592696812, content=👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210130/f777d0b91a25425ba588babbf050d6d1/328b4c90fd7741d090ece3b8f155fc70.jpg, createdBy=25525455713, createdName=牛, createdTime=Wed Feb 24 22:18:18 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1758277, encodeId=96171e5827764, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Fri Feb 26 11:07:07 CST 2021, time=2021-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811748, encodeId=99d4811e485c, content=值得学习及推荐, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210203/aa2a555e80164f58a3a144d7cc0799d9/dc80c6d00a7d4ebab61b224c64402143.jpg, createdBy=85733606129, createdName=185333828dm, createdTime=Fri Aug 21 14:49:23 CST 2020, time=2020-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811674, encodeId=ff4e8116e484, content=日常签到,赚点积分<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a> , beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201110/2d55d24dc5fd419d994b7b920c79731b/d3c8bdca983c4af1b90220a8192e353a.jpg, createdBy=e14e5296465, createdName=飞翔的乌龟, createdTime=Fri Aug 21 09:06:27 CST 2020, time=2020-08-21, status=1, ipAttribution=)]
    2021-02-24

    👍

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2036281, encodeId=deca203628110, content=<a href='/topic/show?id=f818130200e' target=_blank style='color:#2F92EE;'>#NPWT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13020, encryptionId=f818130200e, topicName=NPWT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af68384, createdName=hanhaisha2008, createdTime=Sat Sep 19 03:07:07 CST 2020, time=2020-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926968, encodeId=372592696812, content=👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210130/f777d0b91a25425ba588babbf050d6d1/328b4c90fd7741d090ece3b8f155fc70.jpg, createdBy=25525455713, createdName=牛, createdTime=Wed Feb 24 22:18:18 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1758277, encodeId=96171e5827764, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Fri Feb 26 11:07:07 CST 2021, time=2021-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811748, encodeId=99d4811e485c, content=值得学习及推荐, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210203/aa2a555e80164f58a3a144d7cc0799d9/dc80c6d00a7d4ebab61b224c64402143.jpg, createdBy=85733606129, createdName=185333828dm, createdTime=Fri Aug 21 14:49:23 CST 2020, time=2020-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811674, encodeId=ff4e8116e484, content=日常签到,赚点积分<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a> , beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201110/2d55d24dc5fd419d994b7b920c79731b/d3c8bdca983c4af1b90220a8192e353a.jpg, createdBy=e14e5296465, createdName=飞翔的乌龟, createdTime=Fri Aug 21 09:06:27 CST 2020, time=2020-08-21, status=1, ipAttribution=)]
    2021-02-26 丁鹏鹏
  4. [GetPortalCommentsPageByObjectIdResponse(id=2036281, encodeId=deca203628110, content=<a href='/topic/show?id=f818130200e' target=_blank style='color:#2F92EE;'>#NPWT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13020, encryptionId=f818130200e, topicName=NPWT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af68384, createdName=hanhaisha2008, createdTime=Sat Sep 19 03:07:07 CST 2020, time=2020-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926968, encodeId=372592696812, content=👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210130/f777d0b91a25425ba588babbf050d6d1/328b4c90fd7741d090ece3b8f155fc70.jpg, createdBy=25525455713, createdName=牛, createdTime=Wed Feb 24 22:18:18 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1758277, encodeId=96171e5827764, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Fri Feb 26 11:07:07 CST 2021, time=2021-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811748, encodeId=99d4811e485c, content=值得学习及推荐, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210203/aa2a555e80164f58a3a144d7cc0799d9/dc80c6d00a7d4ebab61b224c64402143.jpg, createdBy=85733606129, createdName=185333828dm, createdTime=Fri Aug 21 14:49:23 CST 2020, time=2020-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811674, encodeId=ff4e8116e484, content=日常签到,赚点积分<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a> , beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201110/2d55d24dc5fd419d994b7b920c79731b/d3c8bdca983c4af1b90220a8192e353a.jpg, createdBy=e14e5296465, createdName=飞翔的乌龟, createdTime=Fri Aug 21 09:06:27 CST 2020, time=2020-08-21, status=1, ipAttribution=)]
    2020-08-21 185333828dm

    值得学习及推荐

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2036281, encodeId=deca203628110, content=<a href='/topic/show?id=f818130200e' target=_blank style='color:#2F92EE;'>#NPWT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13020, encryptionId=f818130200e, topicName=NPWT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af68384, createdName=hanhaisha2008, createdTime=Sat Sep 19 03:07:07 CST 2020, time=2020-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926968, encodeId=372592696812, content=👍, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210130/f777d0b91a25425ba588babbf050d6d1/328b4c90fd7741d090ece3b8f155fc70.jpg, createdBy=25525455713, createdName=牛, createdTime=Wed Feb 24 22:18:18 CST 2021, time=2021-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1758277, encodeId=96171e5827764, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Fri Feb 26 11:07:07 CST 2021, time=2021-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811748, encodeId=99d4811e485c, content=值得学习及推荐, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210203/aa2a555e80164f58a3a144d7cc0799d9/dc80c6d00a7d4ebab61b224c64402143.jpg, createdBy=85733606129, createdName=185333828dm, createdTime=Fri Aug 21 14:49:23 CST 2020, time=2020-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=811674, encodeId=ff4e8116e484, content=日常签到,赚点积分<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a> , beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201110/2d55d24dc5fd419d994b7b920c79731b/d3c8bdca983c4af1b90220a8192e353a.jpg, createdBy=e14e5296465, createdName=飞翔的乌龟, createdTime=Fri Aug 21 09:06:27 CST 2020, time=2020-08-21, status=1, ipAttribution=)]
    2020-08-21 飞翔的乌龟

    日常签到,赚点积分#学习#

    0

相关资讯

Thorax:爬楼梯测试结果与肺切除术后的并发症相关

这项研究结果表明,爬楼梯测试可作为一线的功能筛查试验,以预测胸外科手术后的发病率,并且检查结果较差的患者(<10m)应进一步接受正式的心肺运动试验。

JAMA Oncol :ER+/N+合并多种并发症的老年乳腺癌患者中,化疗与生存期的关系

乳腺癌风险和并发症的发生率随着年龄增长而增加,老年且伴随明显并发症的患者治疗面临着挑战。努力为这些患者提供全面的治疗,最大程度地降低对生活质量的影响,并避免对预期寿命已经有限的患者的功能状态造成损害。

Sci Rep:非小细胞肺癌患者使用术前营养控制状态评分(CONUT)预测术后肺部并发症

术前CONUT评分是手术切除NSCLC患者PPCs和1年死亡率的独立预测指标。

Eur Arch Otorhinolaryngol:减肥手术对咽鼓管功能障碍的影响

最近,有研究人员评估了减肥手术后6个月体重的迅速下降与咽鼓管功能障碍症状的关系。

BMC Microbiol:一种“病毒鸡尾酒”疗法,可以拯救糖尿病并发症

随着饮食、环境和生活习惯的恶化,全球糖尿病患者越来越多,糖尿病足也在患者中也越来越常见。它是糖尿病引起的足部缺血性、神经性和神经缺血性病变,会导致足部出现不同程度感染、溃疡、坏疽。

JAHA:冠状病毒疾病的心血管并发症研究

本荟萃分析的目的旨在探讨COVID-19、SARS和MERS患者心血管并发症的患病率。